The European Parliament has approved legislation regulating the use of pesticides. The law bans certain highly toxic chemicals in pesticides and creates criteria for the use of other substances. The EU will create a list of approved “active substances,” consisting of chemicals that can be used in pesticides. Based on an assessment by the Swedish […]
The FDA’s Center for Drug Evaluation and Research approved 21 new molecular entities (NMEs) in 2008, up from 16 the year before. Three biologic license applications (BLAs) were approved, compared to two in 2007. Three of the NMEs and one of the BLAs were delayed approvals. The drugs with the fastest approval times tend to […]
The Ministry of Knowledge Economy has announced three new “growth engines” for the nation’s economy: green technology, “high-technology industrial convergence” and “valued-added industries.” The Ministry will work to attract KRW 90.5 trillion ($66.9 billion) in private funding by 2013 for 10 projects. The government will contribute KRW 7.3 trillion to the projects, as well as […]
Palo Alto, CA 1/16/09—Varian has announced that its expects fiscal year 2009 first-quarter sales, for the quarter ended January 2, to be $205–$210 million, compared to revenues of $237.4 million for the same period a year ago. “Although we entered the first quarter with a strong backlog for these products and saw solid orders during […]
Product Introductions Horiba launched the waterproof Multi Water Quality Checker U-50 Series for on-site measurement of up to 11 water-quality parameters in environmental waters. WTW GmbH released the handheld single-parameter ProfLine Series for pH, conductivity and dissolved oxygen (DO) measurements, consisting of three new product families: the 3110 series, 3210 series and 3310 series. YSI […]
Marlborough, MA 1/26/09; San Diego, CA and Ann Arbor, MI 1/26/09; San Diego, CA 1/27/08; San Diego, CA 1/28/09—Sequenom has terminated its bid for diagnostics firm EXACT Sciences (see IBO 1/15/09), following Genzyme’s acquisition of certain intellectual property assets held by EXACT related to the fields of prenatal and reproductive health and three million shares […]
Company Announcements In a management buyout, Harvard Bioscience sold its Union Biometrica division, the remaining portion of its Capital Equipment business, in October 2008 for $1 in cash, the assumption of certain liabilities and an earn-out. Harvard Bioscience named Thomas McNaughton, most recently CFO of Tivoli Audio, CFO in November 2008. Jock Fyfe Lennox, senior […]
Pharmaceuticals and Biotech IMS Health forecasts worldwide pharmaceutical sales to increase 4.5%–5.5% this year, on par with 2008, to more than $820 billion (see IBO 10/31/08). The substantial cash holdings of major pharmaceutical companies could increase M&A activities. The target of these acquisitions are expected to be smaller biotech firms that are unable to access […]
As a regular feature of our annual forecast issue, IBO selects a firm from our industry as “company of the year.” In designating the company of the year, IBO recognizes an analytical or life science instrument maker that has accomplished technical, operational and financial achievements. Such achievements are a function of strong financial performance, market […]
While the overall MS market did not quite match the growth initially expected for 2008 (see IBO 1/5/08), it grew more than 8% in the past year. Despite the severe global recession, IBO expects the demand for MS to grow 7.7% in 2009, which will easily put the total market value over the $2.5 billion […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
